| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -42.61M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ALLO returned +75.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +52.6% |
| 1 year | +75.6% |
| 5 years | -91.2% |
| All-time high | $48.16 (May 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ALLO would be worth today ›No. Allogene Therapeutics, Inc. has not paid a dividend in the past 12 months.
Allogene Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol ALLO.
Allogene Therapeutics, Inc. is part of the Healthcare sector.
Allogene Therapeutics, Inc. has a market cap of 722.08M USD, based on the latest quote.
Allogene Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
